Subcutaneous methotrexate in patients with moderate-to-severe psoriasis: a critical appraisal. (2018)
Attributed to:
Clinical, genetic and immune determinants of drug immunogenicity in psoriasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjd.16424
PubMed Identifier: 29399784
Publication URI: http://europepmc.org/abstract/MED/29399784
Type: Journal Article/Review
Volume: 179
Parent Publication: The British journal of dermatology
Issue: 1
ISSN: 0007-0963